Korean red ginseng saponins (ginsenosides) have been reported as having various biological properties, but the combinational effects with commercial antibiotics and the mode of action of ginsenosides remain mostly unknown. In this study, saponins were isolated from Korean red ginseng, and the antibacterial effects of ginsenosides were investigated. Ginsenosides showed antibacterial activities toward pathogenic Gram-positive and Gram-negative bacteria. To elucidate the antibacterial mode of action of ginsenosides, we measured the release of the fluorescent marker calcein from negatively charged PC/PG (1 : 1, w/w) liposomes, which mimic bacterial membranes. The results suggest that ginsenosides may exert antibacterial activity by disrupting the cell membrane. To estimate the general combination effects of ginsenosides and commercial antibiotics, such as kanamycin and cefotaxime, on antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) strains that were clinically isolated from an infected patient, the fraction inhibitory concentration (FIC) indexes were determined by a checkerboard study. The FIC indexes showed synergistic or additive effects between the ginsenosides and antibiotics tested.
The ever-increasing development of pathogenically microbial resistance to traditional antibiotics has reached alarming levels. 1) This has not only made treatment of infectious diseases more problematic, but it has also resulted in the reappearance of many diseases, which were thought to be under control. To treat infections caused by multi drug resistant bacteria the search for new antimicrobial agents has become inevitable and urgent.
The use of natural products, with therapeutic properties, is as ancient as human civilization and, for a long time, minerals, plants and animal products were the main sources of drugs. 2) In particular, plants produce an enormous array of secondary metabolites, and it is commonly accepted that a significant part of this chemical diversity serves to protect plants against microbial pathogens.
3) Therefore, in recent years, there has been growing interest in alternative therapies and in the therapeutic use of natural products, especially those derived from plants. 4) Ginseng has been used for thousands of years in Asian countries, particularly in China, Korea and Japan, due to its wide spectrum of medicinal effects, such as tonic, immunomodulatory and anti-aging activity. 5) Many of its medicinal effects can be attributed to triterpene glycosides known as ginsenosides. Ginsenosides have been reported as having a variety of anticancer effects. Several studies have demonstrated that ginsenosides possess chemopreventive properties. For example, the oral administration of ginsenosides to rats dosed with a carcinogen such as dimethylbenz(a)anthracene (DMBA), urethane or aflatoxin B1, reduced the incidence and size of the tumors that developed. 6) Ginsenosiedes also have a radioprotective effect against radiation-induced double-strand breaks in DNA and immunomodulatory activity, as evidenced by its stimulation of natural killer cells. 7, 8) Although various biological activities of ginsenosides are known, the combinational effects with commercial antibiotics and mode of action of ginsenosides toward human pathogenic bacteria, including clinical isolates of methicillinresistant Staphylococcus aureus (MRSA), have remained mostly unknown.
In this report, we investigated antibacterial activity and the mode of action of ginsenosides against human pathogenic Gram-positive and Gram-negative bacterial strains including the clinical isolates of MRSA. In addition, we examined their possible effects on MRSA in combination with commercial antibiotics.
MATERIALS AND METHODS

Chemicals
The following drugs were obtained from the indicated commercial sources: Mueller-Hinton broth (Difco, Detroit, MI, U.S.A.); propionic acid, nisin, kanamycin, cefotaxime, phosphatidylcholine (PC), phosphatidylglycerol (PG), calcein and other chemicals (Sigma Chemical Co., St. Louis, MO, U.S.A.). Stock solution of propionic acid was prepared in sterile distilled water and that of nisin was prepared in 0.02 N HCl and stored at Ϫ20°C.
Preparation of Ginsenosides Korean red ginseng (KRG, the steamed root of Panax ginseng C. A. MEYER, family Araliaceae) was obtained from the Korea Ginseng and Tabacco Research Institute, Daejeon, Korea, and its voucher specimen was deposited at the same institution. KRG saponins were extracted according to the method described in the previous study. 9) Briefly, KRG saponins were extracted with 80% MeOH (1 ml) from freeze-dried ginseng hairy root tissue (1 g ) and sonicated at 40°C for 1 h. The methanol extract was centrifuged at 1000 rpm for 10 min and evaporated. The dried pellet was re-extracted with water-saturated nBuOH. After evaporating n-BuOH phase to dryness, a pellet (54 mg) was dissolved in sterile distilled water (10 mg/ml as a final concentration). The isolated ginsenosides were ana-lyzed using the HPLC system. /ml) were inoculated into a Mueller-Hinton broth and dispensed at 0.1 ml/well in 96-well microtiter plates. Minimum inhibitory concentrations (MICs) were determined by a serial 2-fold dilution of test compounds, following the recommendations of the Clinical and Laboratory Standards Institute (CLSI). 10) After 24 h of incubation at 37°C, the minimal compound concentration that prevented the growth of a given test organism was determined and was defined as the MIC. Growth was assayed with a microtiter ELISA reader (Molecular Devices Emax, California, U.S.A.), by monitoring absorption at 620 nm.
Kinetics of Bacterial Killing
The kinetics of the bacterial killing of the ginsenosides were evaluated by using MRSA cells.
11) Log-phase bacterial cells (2ϫ10 7 CFU/ml) were incubated with 100 mg/ml of ginsenosides or 20 mg/ml of propionic acid. The cultures were obtained and spread on a Mueller-Hinton agar plate, and then the CFUs (colony forming units) were counted after a 16 h incubation at 37°C.
Calcein Leakage Measurement Calcein-encapsulated large unilamellar vesicles (LUVs) composed of PC/PG (1 : 1, w/w) were prepared by vortexing the dried lipid in dye buffer solution (70 mM calcein, 10 mM Tris, 150 mM NaCl, and 0.1 mM EDTA, pH 7.4). The suspension was freeze-thawed in liquid nitrogen for 11 cycles and extruded through polycarbonate filters (two stacked 100 nm pore size filters) by a LiposoFast extruder (Avestin, Inc., Canada). Untrapped calcein was removed by gel filtration on a Sephadex G-50 column. The leakage of calcein from the LUVs was monitored 2 min after exposure to ginsenosides or nisin by measuring fluorescence intensity at an excitation wavelength of 490 nm and an emission wavelength of 520 nm on a model RF-5301PC spectrofluorophotometer (Shimadzu, Kyoto, Japan). The measurements were performed at 25°C. For determination of 100% dye release, 10% Triton X-100 (20 ml) was added to dissolve the vesicles. The percentage of dye leakage caused by the compounds was calculated as follows:
where F is the fluorescence intensity achieved by the compounds and F 0 and F t are the fluorescence intensities without the compounds and with Triton X-100, respectively.
Combination Effect of Ginsenosides with Commercial Antibiotics The combination effect of commercial antibiotics and ginsenosides was determined by a checkerboard assay and the effects were evaluated using fractional inhibitory concentration (FIC) indexes. FIC indexes were calculated using the following formula: FIC indexesϭ(MIC Drug A in combination/MIC Drug A alone)ϩ(MIC Drug B in combination/MIC Drug B alone). In brief, the MRSA cells (2ϫ10 7 /ml) were inoculated into a Mueller-Hinton broth and dispensed at 0.1 ml/well in 96-well microtiter plates. MICs were determined by a serial twofold dilution of ginsenosides and/or antibiotics. After 24 h of incubation at 37°C, the minimal compound concentration that prevented the growth of a given test organism was determined and was defined as the MIC. The MIC values were determined by three independent assays and the FIC indexes were calculated from both the FIC indexes of ginsenosides and antibiotics.
12) The FIC indexes Յ0.5, 0.5ϽFICՅ1, 1ϽFICՅ2, and Ͼ2 were defined as synergistic, additive, indifferent, and antagonism, respectively.
13) RESULTS
In Vitro Antibacterial Activity The antimicrobial effects of ginsenosides on human pathogenic bacteria, including clinical isolates of antibiotic-resistant bacteria, were investigated and described as the MIC. In the current study, propionic acid and nisin were used as a positive control; propionic acid is an antibacterial agent widely used as a food preservative 14) and nisin is a polypeptide antibiotic produced by different strains of Streptococcus lactis belonging to Lancefield group N, used mainly in the food and dairy industries. 15, 16) Ginsenosides, with an MIC value of 100 mg/ml, showed antibacterial activity against Gram-positive and Gram-negative bacterial strains including the clinical isolates of MRSA. Ginsenosides exhibited less potent activity than nisin, showing MIC values of 40 mg/ml on Gram-positive bacterial strains. Additionally, these compounds also exhibited less potent activity than propionic acid, showing MIC values of 20-50 mg/ml on all bacterial strains (Tables 1, 2) .
To assess the killing potency of ginsenosides, we conducted a time-killing assay. The killing of kinetic assays was done by counting the CFUs of MRSA. Ginsenosides showed cidal activity against MRSA. The CFUs of the MRSA cells, with the MIC value of ginsenosides, significantly decreased in a time-dependent manner, similar to the decrease of CFUs in the presence of propionic acid (Fig. 1) .
Calcein Leakage Measurement To elucidate the antibacterial mode of action of ginsenosides, we measured the release of the fluorescent marker calcein from liposomes. We employed negatively charged LUVs composed of 1 : 1 (w/w) PC/PG lipids used for mimicking the major components of the cell membrane of bacteria. 17, 18) The percentage of calcein leakage 2 min after exposure to ginsenosides or nisin was used to assess the ability to permeabilize the membrane. The results showed that 100 mg/ml of ginsenosides (at the MIC) induced 52.1% leakage of calcein from negatively charged vesicles, whereas 40 mg/ml of nisin (at the MIC) only induced approximately 10% of leakage of the dye (Fig. 2) .
The Combination Effect of Ginsenosides with Antibiotics To estimate the general effect regarding the combination of ginsenosides and commercial antibiotics, such as kanamycin and cefotaxime, on antibacterial activity against MRSA, the FIC indexes were determined by a checkerboard study. 12) When tested alone, ginsenosides and other antibiotics showed weak antibacterial activity, however, the combination of kanamycin or cefotaxime with ginsenosides significantly improved antibacterial activity (Table 2 ). FIC indexes of Յ0.5 are considered synergistic, whereas indexes greater than 0.5 are considered additive. 13) Based on MICs and FIC calculations, the combination of ginsenosides and kanamycin had a synergistic or additive effect against MRSA, whereas the combination of ginsenosides and cefotaxime had only an additive effect ( Table 2 ). The FIC indexes were calculated as described in Materials and Methods.
DISCUSSION
Plants have developed an arsenal of chemicals in order to survive attacks by microbial invasion. Until now, many different antimicrobial phytochemicals have been isolated from several plants. Since these compounds have relative novel chemical structures and antimicrobial mechanisms, there has been a growing interest in antimicrobial phytochemicals. 19) The present study aimed to assess the antibacterial effects of ginsenosides on human pathogenic bacteria including the clinical isolates of MRSA, as well as the combination with commercial antibiotics and their mode of action.
Ginsenosides exhibited less potent but broad-spectrum antibacterial activity against Gram-positive and Gram-negative bacterial strains, including the clinical isolates of MRSA, than that of propionic acid and nisin regarding MIC values as a positive control (Tables 1, 2 ). Ginsenosides have remarkable potential as an antibacterial agent in treating Gram-positive and Gram-negative bacterial infectious diseases. Most antibiotics show antimicrobial activity by cidal or static action. Ginsenosides exhibited similar killing potency to propionic acid, which is known to be a cidal agent toward bacteria; the antibacterial activity of ginsenosides toward MRSA is due to the killing action, as described by time-killing plots with MRSA (Fig. 1) .
In general, a large number of the biological effects of saponins have been ascribed to their action on membranes. 20) To provide information on the mode of antibacterial action of ginsenosides, we investigated their ability to permeabilize from negatively charged LUVs, which mimic the bacterial cell membranes (Fig. 2) . These results showed that calcein was released from LUVs in a dose-dependent manner after treatment with ginsenosides, suggesting that these compounds cause a perturbation to the lipid component of the plasma membrane.
Combination antibiotic therapy has been used mainly to broaden the antibacterial spectrum and to prevent the development of resistance. The combination effect of ginsenosides and commercial antibiotics such as kanamycin and cefotaxime, against the clinical isolates of MRSA, was investigated. The clinical isolates of MRSA were resistant to kanamycin and cefotaxime ( The bacterial cells were incubated with 100 mg/ml of ginsenosides or 20 mg/ml of propionic acid which was used as a positive control. Viability was determined every 30 min by using colony forming units (CFUs) and was expressed as a percentage of survivals, and the error bars represent the standard deviation (S.D.) values for three independent experiments, performed in triplicate. a) For the combination studies, the first value represents the MIC relative to the concentration of the first compound listed and the second value represents the MIC relative to the concentration of the second (or third) compound listed.
phenicol (data not shown). The combination of ginsenosides and kanamycin had a synergistic or additive effect against MRSA, showing on FIC index of 0.375-0.75 whereas a combination of ginsenosides and cefotaxime had only an additive effect against MRSA, showing a FIC index of 0.625.
Kanamycin inhibits protein synthesis by binding on the ribosomal 30S or 50S subunits, and cefotaxime inhibits cell wall synthesis by blocking transpeptidase reaction in bacteria. 21, 22) Some studies have demonstrated that impermeability of the bacterial plasma membrane plays an important role in resistance to kanamycin. 23) Therefore, if the entry of kanamycin into the cytoplasm is increased by changes in the permeability of the plasma membrane, the antibacterial activity of kanamycin, against kanamycin-resistant bacterial strains, could be increased. It was elucidated that the combination of ginsenosides plus kanamycin was superior to that of ginsenosides plus cefotaxime. In other words, when ginsenosides interact with the membrane, this raises the permeability of the plasma membrane to kanamycin. The mechanism by which such combination achieves synergy is believed to facilitate the entry of kanamycin into cells, after the partial disruption of the cell membrane, through the action of ginsenosides.
